Clinical Trial Update: IBRX-042 In Participants With HPV-Associated Tumors [Phase 1]

View source ↗

Summary

This clinical trial update covers the Phase 1 study of IBRX-042 in HPV-related carcinoma and notes that the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus-related Carcinoma

Drugs mentioned

• IBRX-042

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: HPV-Related Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING